跳至主要内容
临床试验/NCT06068335
NCT06068335招募中不适用

Innate Immunity in Allergic Asthma

University of Central Florida1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年10月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
To determine which parameters of the established type-2 signature obtained in vitro is significantly different between healthy controls, allergic individuals, and asthmatic individuals ex vivo.

研究概览

简要总结

The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be at least 18 years of age
  • no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.

排除标准

  • Pregnant women and prisoners will be excluded from the study.
  • Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.

结局指标

主要结局

To determine which parameters of the established type-2 signature obtained in vitro is significantly different between healthy controls, allergic individuals, and asthmatic individuals ex vivo.

时间窗: 1 year

次要结局

  • To determine ex vivo whether any of the identified disease-specific type-2 parameters can be modified (brought back to healthy control levels) through the use of investigational compounds.(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验